Herein, we explored the puzzling co-occurrence of somatic mutations in the two enhancer activating chromatin modifier proteins CREBBP and KMT2D in B-cell lymphomas. The gene discussed is CREBBP; the disease is B-cell non-Hodgkin lymphoma.